The American Cancer Society predicts 1 in 8 men will be diagnosed with prostate cancer in their lifetime.

As the standards of care for prostate cancer change, new drugs, combination therapies, and trials enter the therapeutic space ...

Profound Medical (NASDAQ:PROF) and Telix Pharmaceuticals (NASDAQ:TLX) have signed a co-education agreement aimed at increasing physician awareness of how advanced diagnostic imaging can support ...

"The number of men living with prostate cancer also continues to rise, so it's vital that we see investment in prostate ...

VIR-5500 and [²¹²Pb]PSV359 received FDA fast track designations for prostate cancer and solitary fibrous tumors, respectively ...

When David Brown learned he had prostate cancer at 48, survival was not his only concern. A husband, father, and businessman, he wanted to understand how treatment could control his cancer and affect ...

Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine whether prostate tumors remain sensitive to treatment or evolve into a more ...

Men in England diagnosed with incurable advanced prostate cancer are more likely to survive for at least three years than ...

Bruce Arians shared his prostate cancer survival story during the NFL's "Crucial Catch" week, urging men to get a simple PSA ...

Men newly diagnosed with prostate cancer face a range of treatment options, from robotic surgery and focal therapy to ...

Last time, I wrote that the chemotherapy drug 'docetaxel,' which was scheduled for a total of six sessions, was discontinued ...

Kevin Mortimer has been described as a 'super responder' to triplet therapy - a method that attacks the cancer with three treatments at once.